Skip to content
OpenCapital
Get started

Context Therapeutics Inc. CNTX Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

EPS-$0.04Beat by $0.01
EPS estimate-$0.05

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.10

Versus estimates

Diluted EPS

Q1 2026-$0.09Beat by $0.03Q4 2025-$0.14Miss by $0.03Q3 2025-$0.10Miss by $0.01Q2 2025-$0.09Miss by $0.03Q1 2025-$0.05In line
Q4 2024-$0.04Beat by $0.01

Ask the moment Context Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Context Therapeutics Inc. report Q4 2024 earnings?
Context Therapeutics Inc. (CNTX) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Context Therapeutics Inc.'s Q4 2024 revenue and EPS?
Context Therapeutics Inc. reported eps of $-0.04 for Q4 2024.
Did Context Therapeutics Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.05 by $0.01.
Where can I find Context Therapeutics Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001842952-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.